8-K filing — VISTA CREDIT STRATEGIC LENDING CORP.
Filed: 2026-09-09 AccNo: 0001193125-26-386477 Size: 153 KB Item 8.01: Other Events
News
Source-attributed headlines with timestamps and links to the companies and crypto markets they mention.
Latest Coverage
30 headlines
Filed: 2026-09-09 AccNo: 0001193125-26-386477 Size: 153 KB Item 8.01: Other Events
Cooper Companies (NASDAQ:COO) reported quarterly earnings of $1.15 per share which beat the analyst consensus estimate of $1.12 by 2.68 percent. This is a 4.55 percent increase over earnings of $1.10 per share from the
Enbridge Inc. (TSX:ENB) (NYSE:ENB) ("Enbridge" or the "Company") announced today that, through a wholly-owned subsidiary, it has entered into a definitive agreement with wholly-owned subsidiaries of
Filed: 2026-09-09 AccNo: 0001562401-26-000050 Size: 6 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Filed: 2026-09-09 AccNo: 0001213900-26-098403 Size: 365 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits
Filed: 2026-09-09 AccNo: 0000074208-26-000077 Size: 9 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Filed: 2026-09-09 AccNo: 0001213900-26-098402 Size: 194 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders
Filed: 2026-09-09 AccNo: 0001728951-26-000057 Size: 519 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
CooperCompanies today announced the completion of its strategic review process first announced in December 2025. The comprehensive process focused on identifying opportunities to enhance long-term shareholder value
Filed: 2026-09-09 AccNo: 0001193125-26-386469 Size: 518 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Filed: 2026-09-09 AccNo: 0001104659-26-106331 Size: 525 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
TD Synnex (NYSE:SNX) has outperformed the market over the past 15 years by 9.02% on an annualized basis producing an average annual return of 22.05%. Currently, TD Synnex has a market capitalization of $20.66 billion.
Filed: 2026-09-09 AccNo: 0002077096-26-000244 Size: 195 KB Item 8.01: Other Events
Filed: 2026-09-09 AccNo: 0001104659-26-106324 Size: 250 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 5.07: Submission of Matters to a Vote of Security Holders
Filed: 2026-09-09 AccNo: 0001193125-26-386460 Size: 9 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Filed: 2026-09-09 AccNo: 0001104659-26-106321 Size: 182 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Skillsoft (NYSE:SKIL) reported quarterly earnings of $1.17 per share which beat the analyst consensus estimate of $0.83 by 40.96 percent. This is a 27.17 percent increase over earnings of $0.92 per share from the same
Monteverde & Associates PC is investigating four major merger and acquisition deals to determine if they are fair to shareholders: Auddia's merger with McCarthy Finney (1:1 stock exchange), Bio-Techne's sale to Merck KGaA ($73/share), Caesars Entertainment's sale to Fertitta Gaming ($31/share plus ticking consideration), and Colony Bankcorp's merger with First Reliance Bancshares ($19.75 cash or 0.94 stock exchange).
Energy Transfer, a midstream pipeline operator, offers a 6.3% forward yield with strong distribution coverage of 2.28x in H1 2026. The company's toll-based business model insulates it from commodity price volatility, and it allocates about half its distributable cash flow to distributions while maintaining room for 3-5% annual increases. Operating as an MLP, it provides tax-efficient distributions to investors.
The Computer-Micro Computers industry is experiencing strong growth driven by enterprise PC replacement cycles, Windows 11 adoption, and emerging AI PC demand. The industry has outperformed the S&P 500 by 46.2% over the past year and trades at a forward P/E of 31.16X. Key players Dell Technologies and HP are benefiting from increased enterprise IT spending and AI workload adoption, though rising memory and storage costs present headwinds.
Microchip Technology (MCHP) is expanding its automotive connectivity portfolio with an open-standard ASA Motion Link (ASA-ML) display connectivity solution for software-defined vehicles. The company's automotive business is gaining momentum with 29.3% year-over-year sales growth and automotive representing 15% of Q1 FY2027 revenues. However, MCHP faces intense competition from Texas Instruments and Analog Devices, both of which have strong automotive portfolios and growing market share. MCHP trades at a forward P/E of 18.33 and holds a Zacks Rank #3 (Hold) rating.
Monteverde & Associates PC is investigating four merger transactions to determine if shareholders are receiving fair value. The investigations cover Iridium Communications' sale to Rocket Lab, VerifyMe's merger with Open World Ltd, Valaris' sale to Transocean Ltd, and Standard Biotools' merger with Treeline Biosciences. The firm is offering free consultations to shareholders with concerns about these deals.
Pepeto, an Ethereum-based cryptocurrency, has raised $10.958 million in presale funding with an operational zero-fee exchange (PepetoSwap). Analysts predict Cardano could reach $2.90, representing a potential 14x return from its current $0.22 price level. The article compares Pepeto's early growth trajectory to Shiba Inu's early success, suggesting smart money is targeting smaller presale projects over established cryptocurrencies.
Avino Silver & Gold Mines Ltd. (ASM) is experiencing high implied volatility in its October 2026 call options, suggesting traders expect significant price movement. However, the company holds a Zacks Rank #4 (Sell) rating, with analysts downgrading estimates over the past 60 days, reducing consensus earnings from 10 cents to 6 cents per share. The elevated volatility may present opportunities for premium-selling strategies rather than bullish positioning.
Trident Digital Tech Holdings (Nasdaq: TDTH) completed an US$8 million private placement of 20 million Class B ordinary shares at US$0.40 per share. The proceeds will fund digital infrastructure, enterprise AI initiatives, and government technology projects across Africa and Asia-Pacific, including Ghana's digital tax platform and the IRMA Asia joint venture. The company projects Sikaflow revenue run-rate of approximately US$65 million annualized by end of 2026.
Alibaba Group Holding Limited faces a class action securities fraud lawsuit covering the period from June 26, 2025 to June 24, 2026. The lawsuit alleges the company failed to disclose its control by or affiliation with China's Ministry of Industry and Information Technology (MIIT), which classified it as a Chinese military company under the National Defense Authorization Act. Additionally, Anthropic accused Alibaba of illicitly accessing its Claude AI model through fraudulent accounts. These revelations caused Alibaba's stock to drop approximately 3.9% on June 10, 2026, and an additional 2.7% on June 24, 2026. The deadline to file a lead plaintiff motion is October 5, 2026.
Tandem Diabetes (TNDM) is positioned for growth with its expanding product roadmap including the Mobi tubeless pump, new CGM integrations, and AIDANET closed-loop program. The company's pay-as-you-go reimbursement model aims to lower upfront barriers and boost recurring supply revenue. However, macroeconomic pressures, reimbursement sensitivity, competitive threats, and the impact of GLP-1 drugs on insulin therapy demand pose significant headwinds to sustained profitability.